|
|
|
|
|
|
ASSOCIATE DEAN FOR ACADEMIC AFFAIRS AND EDUCATIONAL INNOVATION West Virginia University School of Pharmacy
GENERAL INFORMATION
EDUCATION & TRAINING
PROFESSIONAL EXPERIENCE
SCHOLARLY ACTIVITY Publications (Refereed Journals) Kidd RS, Stamatakis MK. Comparison of students’ performance and satisfaction of a clinical pharmacokinetics course delivered live and by interactive videoconferencing. Am J Pharm Educ 2006; 70(1): Article 10. Slain D, Abate M, Hodges BM, Stamatakis MK, Wolak S. An interactive response system to promote active learning in the doctor of pharmacy curriculum. Am J Pharm Educ 2004;68:Article 117. Stamatakis MK, Schreiber JM, Slain D, Gunel E. Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen. Am J Health-Syst Pharm 2003;60:1564-8. Abate MA, Stamatakis MK, Haggett RR. Excellence in curriculum development and assessment. Am J Pharm Educ 2003;67 (3:Article 89):1-21. Stamatakis MK. Strategies for treatment and prevention of acute renal failure. J Pharm Prac 2002;14(5):392-404. Abate MA, Stout PJ, Stamatakis MK, Gannett PM, Dunsworth TS. Development and evaluation of computerized problem-based learning cases emphasizing basic sciences concepts. Am J Pharm Educ 2000;64(1):74-82. Stamatakis MK, Meyer-Stout PJ. Disintegration performance of renal multivitamin supplements. J Renal Nutr 1999;9(2):78-83. Stamatakis MK, Leader WG, Tracy TS. Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions. Am J Health-Syst Pharm 1999;56(3):246-8. Stamatakis MK, Alderman JM, Meyer-Stout PJ. Effect of pH on in vitro disintegration of phosphate binders. Am J Kidney Dis 1998;32(5):808-12. Stamatakis MK, Pecora PG, Gunel E. Factors influencing adherence in chronic dialysis patients with hyperphosphatemia. J Renal Nutr 1997;7(3):144-8. Eddy JT, Stamatakis MK, Makela EH. Saccharomyces boulardii for the treatment of Clostridium difficile-associated colitis. Ann Pharmacother 1997;31:919-21. Schmidt R, Horn E, Richards J, Stamatakis M. Survival after metformin-associated lactic acidosis in peritoneal dialysis-dependent renal failure. Am J Med 1997;102:486-8. Stamatakis MK, Richards JG. Quinupristin/dalfopristin-cyclosporine interaction. Ann Pharmacother 1997;31:576-8. Stamatakis MK. Optimizing drug therapy in renal failure. Pharmacy Times 1996; Nov: 7HPT - 14HPT. Stamatakis MK, Sorkin MI, Moss AH. Toxicity following IP trimethoprim-sulfamethoxazole in a CAPD patient. Peritoneal Dial Int. 1995;15(3):180-1. Stamatakis MK, Seth SK. Treatment of chronic hypocalcemia with intraperitoneal administration of calcium. Am J Health-Syst Pharm. 1995;52:201-3. Invited Book Chapters/Case Book Chapters Stamatakis MK. Acute renal failure. In Pharmacotherapy Principles & Practice, 1st edition. Chisholm M, Schwinghammer TL, Wells BG, DiPiro JT, Kolesar JM, and Malone PM. McGraw Hill Companies, Inc. New York, NY, 2007. Stamatakis MK. Chronic Kidney Disease. In: Drug-Induced Diseases: Prevention, Detection, and Management. J Tisdale, D Miller (eds.) American Society of Health-System Pharmacists, Bethesda, MD, 2005. Stamatakis MK. Drug-induced acute renal failure. In: Pharmacotherapy casebook: a patient-focused approach, 6th edition. T. Schwinghammer, (ed.) The McGraw-Hill Companies Inc., New York, NY, 2005. Stamatakis MK. Hyperkalemia, hyperphosphatemia, and hypercalcemia. In: Pharmacotherapy casebook: a patient-focused approach, 6th edition. T. Schwinghammer, (ed.) The McGraw-Hill Companies Inc., New York, NY, 2005. Stamatakis MK. Algorithm for treatment of volume overload in chronic renal failure. In: A Guide to Clinical Decision-Making: The PSAP Algorithms, 3rd edition. American College of Clinical Pharmacy, Kansas City, MO, 2005. Stamatakis MK. Chronic kidney disease. In: Pharmacotherapy self-assessment program, 4th edition. BA Mueller, K Bertch, T Dunsworth, S Fagan, et al. (eds.) American College of Clinical Pharmacy, Kansas City, MO, 2003. Stamatakis MK. Drug-induced acute renal failure. In: Pharmacotherapy casebook: a patient-focused approach, 5th edition. T. Schwinghammer, (ed.) The McGraw-Hill Companies Inc., New York, NY, 2002. Stamatakis MK. Hyperkalemia, hyperphosphatemia, and hypercalcemia. In: Pharmacotherapy casebook: a patient-focused approach, 5th edition. T. Schwinghammer, (ed.) The McGraw-Hill Companies Inc., New York, NY, 2002. Stamatakis MK, Joy MS. Updates in chronic renal failure and hemodialysis. In: Pharmacotherapy self-assessment program, 3rd edition. Carter B, (ed.) American College of Clinical Pharmacy, MO, 1999. Stamatakis MK. Drug-induced acute renal failure. In: Pharmacotherapy: a patient-focused approach, 2nd edition. T. Schwinghammer, (ed.) Appleton and Lange, CT, 2000:109-11. Stamatakis MK. Drug-induced acute renal failure. In: Instructor's Guide to Pharmacotherapy: a patient-focused approach, 2nd edition. T. Schwinghammer, (ed.) Appleton and Lange, CT, 2000:126-9. Bond BK, Stamatakis MK. Hyperkalemia and hyperphosphatemia in chronic renal failure. In: Pharmacotherapy: a patient-focused approach, 2nd edition. T. Schwinghammer, (ed.) Appleton and Lange, CT, 2000:123-5. Bond BK, Stamatakis MK. Hyperkalemia and hyperphosphatemia in chronic renal failure. In: Instructor's Guide to Pharmacotherapy: a patient-focused approach, 2nd edition. T. Schwinghammer, (ed.) Appleton and Lange, CT, 2000:152-6. Stamatakis MK. Constipation. In: Pharmacotherapy: a patient-focused approach, 1st edition. T. Schwinghammer, (ed.) Appleton & Lange, CT, 1996:154-8. Abstracts and Poster Presentations See CJ, Congdon HB, Ridgway WC, Stamatakis MK, Jackson J. Interdisciplinary education in rural West Virginia. Am J Pharm Educ 2006; (American Association of Colleges of Pharmacy Annual Meeting, San Diego, CA, July 2006) Clutter J, Ponte C, Ridgway WC, Stamatakis MK, Stump S. Faculty and student perspectives on classroom incivility. Am J Pharm Educ 2004; 68(2): 63-4. (American Association of Colleges of Pharmacy Annual Meeting, Salt Lake City, UT, July 2004) Slain D, Abate M, Hodges B, Stamatakis MK. Evaluation of an interactive response system to promote active learning and skills development in the Doctor of Pharmacy curriculum. Am J Pharm Educ 2003;67(3): 70. (American Association of Colleges of Pharmacy Annual Meeting, Minneapolis, MN, July 2003) Stamatakis MK, Hudson JQ, Joy MS, et al. Treatment of hyperphosphatemia and secondary hyperparathyroidism in patients undergoing dialysis: results from the nephrology drug surveillance network. Pharmacotherapy 2002;22(3):414-15. (American College of Clinical Pharmacy Spring Practice and Research Forum, Savannah, GA, April 2002). Joy MS, Hudson JQ, Walton T, Stamatakis MK, Miller G, Smith C. Nephrology PRN surveillance study: cardiovascular disease and treatment in dialysis patients. Pharmacotherapy 2002;22(3):415. (American College of Clinical Pharmacy Spring Practice and Research Forum, Savannah, GA, April 2002). Hudson JQ, Joy MS, Stamatakis MK, Walton T, Miller G, Smith C. Nephrology Practice and Research Network surveillance study: anemia management in dialysis patients. Pharmacotherapy 2002;22(3):414. (American College of Clinical Pharmacy Spring Practice and Research Forum, Savannah, GA, April 2002). Joy MS, Hudson JQ, Stamatakis MK, Walton T, Miller G, Smith C. Description of the Nephrology PRN drug surveillance network program. Pharmacotherapy 2002;22(3):415. (American College of Clinical Pharmacy Spring Practice and Research Forum, Savannah, GA, April 2002). Walton T, Joy MS, Stamatakis MK, Hudson JQ, Miller G, Smith C. Nephrology PRN surveillance study: treatment of diabetes mellitus in dialysis patients. Pharmacotherapy 2002;22(3):414. (American College of Clinical Pharmacy Spring Practice and Research Forum, Savannah, GA, April 2002). Stamatakis MK, Schreiber JM, Slain D. Vancomycin administration with F-8 polysulfone hemodialysis: experience with a post-hemodialysis dosing protocol. Pharmacotherapy 2001;21(10):1279. (American College of Clinical Pharmacy Annual Meeting, Tampa, FL, October 22, 2001, poster) Schreiber JM, Stamatakis MK, Slain D. Vancomycin administration with medium-flux polysulfone hemodialysis membranes: Comparison of traditional to post-hemodialysis dosage regimens. International Pharmaceutical Abstracts. (American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, Nevada, December 2000, poster) Casdorph DL, Stamatakis MK. Physical assessment education in nontraditional Doctor of Pharmacy degree program curricula: A survey of pharmacy schools. International Pharmaceutical Abstracts. (American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, Nevada, December 2000, poster) McIntire TM, Casdorph DL, Stamatakis MK. Blending pharmacy basics and clinical skills in the laboratory environment. (Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, CA, July 2000, poster) Stamatakis MK, Stout PJ, Alderman J. Pharmaceutical performance of phosphate binders used in the treatment of patients with end stage renal disease. West Virginia University School of Medicine Research Day. March 19, 1999, poster. Stamatakis MK. Effectiveness of a pharmacist-initiated continuity of care program for chronic dialysis patients. International Pharmaceutical Abstracts 1998. (American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, Nevada, December 1998, poster) Stout PJ, Stamatakis MK. Disintegration performance of phosphate binders used in the treatment of patients with end stage renal disease. American Association of Pharmaceutical Scientists Annual Meeting and Exposition, San Francisco, CA, November 1998, poster. Stamatakis MK, Alderman JA, Stout PJ. Disintegration performance of phosphate binders. Pharmacotherapy 1997;17(1):190. (American College of Clinical Pharmacy Spring Practice and Research Forum, Panama City, FL, April 1997, poster) Makela EH, Stamatakis MK, Hill LA. Scientific/scholarly writing for publication: A course for B.S. in pharmacy candidates. American Association of Colleges of Pharmacy Annual Meeting, Indianapolis, IA, July 1997, poster. Alderman JA, Stamatakis MK, Stout PJ. Disintegration performance of phosphate binders. West Virginia University Undergraduate Research Seminar, Morgantown, WV, October 1996, poster. Stamatakis MK, Brun JC, Stout PJ. Disintegration performance of renal multivitamin supplements. Pharmacotherapy 1996;16(1):41-2. (American College of Clinical Pharmacy Winter Practice and Research Forum, Monterey, CA, February 1996, poster) Stout PJ, Brun JC, Kesner J, Glover D, Stamatakis M. Performance assessment of vitamin supplements: efficacy issues. Pharm Res 1996;13:S71. (American Association of Pharmaceutical Scientists Annual Meeting and Exposition, Seattle, WA, October 1996, poster) Braun J, Lucus W, Stamatakis M, Stout PJ. Disintegration performance of renal and ophthalmic vitamin supplements - a question of product efficacy. West Virginia University Undergraduate Research Seminar, Morgantown, WV, October 1995, poster. Pecora PG, Stamatakis MK. Increasing phosphorus control in ambulatory dialysis patients: Use of an audio-visual educational program. International Pharmaceutical Abstracts. 1994:31(21):2328. (American Society of Hospital Pharmacists Midyear Clinical Meeting, Miami Beach, FL. December 1994, poster) Stamatakis MK, Seth SK. Intra-peritoneal administration of calcium gluconate in a continuous ambulatory peritoneal dialysis patient. International Pharmaceutical Abstracts 1993:30(22):2563. (American Society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, GA, December 1993, poster) Stamatakis MK, Seth SK. Effects of GM-CSF on ganciclovir-induced neutropenia in kidney transplant patients. International Pharmaceutical Abstracts 1993:30(22):2557. (American Society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, GA, December 1993, poster) Coyle JD, Carnes CA, Stamatakis MK, Schaal SF, Muir WW. Initial in vivo evaluation of a computer-based infusion system for achieving and maintaining multiple, sequential, constant serum concentrations of procainamide. Pharmacotherapy; 1991:11(1)96. (American College of Clinical Pharmacy Winter Practice and Research Forum, Fort Lauderdale, FL, February 1991, poster) PRESENTATIONS
“New drug update.” Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, July 9, 2002.
“Low-dose dopamine.” Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, February 17, 2001.
“Does low-dose dopamine improve renal function in acute renal failure?” Annual Meeting of the American College of Clinical Pharmacy, Tampa, FL, October 22, 2001.
“Optimizing drug therapy in renal failure: tools for the pharmacist.” West Virginia Pharmacists Association CE Expo Meeting. Flatwoods, WV, February 17, 2001.
"WVU internal grants programs" WVU Faculty Development Series. Morgantown, WV, September 14, 2000. "Antibiotic dosing in renal failure." Ruby Memorial Hospital Pharmacy Clinical Conference. Morgantown, WV, October 26, 1999. "Hyperphosphatemia in ESRD: Treatment with phosphate binders." Dialysis Unit Continuing Education, Beckley WV, May 6 1999; Cranberry PA, July 21, 1999; Harrisburg PA, August 1, 1999. "New Pharmacotherapies for the treatment of hyperphosphatemia and secondary hyperparathyroidism." Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, June 1998. "Updates on the treatment of peritonitis." Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, February 1997. "Tacrolimus therapeutic drug monitoring." West Virginia University Transplant Protocol Development Meeting, Morgantown, WV, November 1997. "Cyclosporine therapeutic drug monitoring." West Virginia University Transplant Protocol Development Meeting, Morgantown, WV, November 1997. "History of clinical pharmacy services in the outpatient hemodialysis setting." Nephrology Practice and Research Network dinner meeting. American College of Clinical Pharmacy Spring Practice and Research forum, Panama City, FL, April 1997. "Interference of misoprostol with indomethacin in the treatment of lithium-induced diabetes insipidus." Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, November 1997. "Interpretation of laboratory values." Pharmacy Continuing Education. The West Virginia Society of Hospital Pharmacists Spring Symposium, Wheeling, WV, 1995. "Drug dosing in renal failure: Tools for the pharmacist." Pharmacy Continuing Education. The West Virginia Society of Hospital Pharmacists Spring Symposium, Wheeling, WV, 1995. "Once daily aminoglycosides." Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, January 1995. " Drug dosing in renal failure: Tools for the health-care team." Nursing Continuing Education. Bluefield, WV, December 1994. "Optimizing drug therapy in renal failure - tools for the pharmacist." Continuing Pharmacy Education. 35th Annual Pharmacy Alumni Seminar and 11th Annual Pharmacy Law Lecture, Morgantown, WV, April 1994. "Nephrology in a nutshell." Physician Office Center Pharmacy, West Virginia University, Morgantown, WV, August 1994. "Pharmacokinetics of newer drugs in patients with renal impairment." Continuing Medical Education. Nephrology Grand Rounds, Morgantown, WV, March 1994. "Continuous ambulatory peritoneal dialysis: implications for the pharmacist." Continuing Pharmacy Education. The Ohio State University Medical Center. February 1993. "Urea and creatinine clearance in continuous ambulatory peritoneal dialysis (CAPD): enhancement with oral pentoxifylline." Pharmacy Continuing Education, The Ohio State University College of Pharmacy. June 1992. "Treatment of diuretic resistance in CRF: continuous infusion loop diuretics." Continuing Pharmacy Education. The Ohio State University Medical Center. January 1992. "Drugs of abuse." Presented multiple times to Elementary schools as part of the Drug Abuse Education Committee. September 1988 - June 1989. GRANTS “Evaluation of an interactive response system to promote active learning/skills development.” West Virginia University Research Incentive Competitive Grants Program, $19,200, 2002, Co-investigator. “In vitro disintegration and dissolution of nutritional supplements and vitamins.” West Virginia University Research Corporation Annual Grants Competition, $15,000, 2001, Co-principal investigator. "Development of computerized multidisciplinary problem-based learning cases with concept map integration." Fund for the Improvement of Post-Secondary Education, $182,538, 1996-99, Co-investigator for years 2 – 3. "Measurement of drug concentrations in biological and pharmaceutical matrices", Research Support for Central Funding's Indirect Costs Fund, West Virginia University, $26,550, 1997, Co-principal investigator. "Development, implementation and assessment of a pharmaceutical care service in an ambulatory hemodialysis center", ASHP Foundation Grants Program for New Pharmacy Practice Researchers, $5,992, 1996, Principal investigator. "Stability of vancomycin and ceftazidime in peritoneal dialysis solutions", West Virginia University Senate Grant for Research and Scholarship, $4,200, 1996, Principal investigator. "Development of a new course to teach application of clinical skills to pharmacy practice", Eli Lilly & Co., $4,690, 1995, Principal investigator. CURRENT TEACHING RESPONSIBILITIES
PHAR 723 – Pharmaceutical Care Lab 3 (course coordinator and faculty instructor); required course for second year Doctor of Pharmacy students.
PHAR 730 - Pathophysiology/Therapeutics 4 (nephrology section coordinator and instructor); required course for third year Doctor of Pharmacy students.
PHAR 724 - Pharmaceutical Care Lab 4 (laboratory instructor); required course for first year Doctor of Pharmacy students.
Advanced Clinical Pharmacokinetics, Practicum 3, Practicum 4 (guest instructor) Experiential Teaching PHAR 764 - Teaching Experiential Rotation Preceptor.
PHAR 765 – Administration Experiential Rotation Co-preceptor.
HONORS AND AWARDS
Elected to membership in Phi Lambda Sigma, national pharmacy leadership society (2007). West Virginia University School of Pharmacy Teacher of the Year, First year Pharm.D. student class (2002). RECENT COMMITTEE APPOINTMENTS
West Virginia University School of Pharmacy Executive Committee (2002 – present) Curriculum Committee (1994 - present)
Awards Committee
Academic Standards (2002 – present) Assessment Committee (1998 - present) School of Pharmacy Renovation Committee (2006 – present) Business Manager Search Committee (2006-2007) Strategic Planning Committee (2006) Dean Search Committee (2005 – 2006) Director of Introductory Pharmacy Practice Experiences Search, Chair (2006) School-wide Faculty Evaluation Committee (2000-2001) Self-study Steering Committee for Accreditation of the Professional Program
West Virginia University Health Sciences Center Faculty Development Advisory Committee (2004 – present) Assistant/Associate Dean’s Council (2002 – present) Students Rights and Responsibilities Committee (2003 – present) Faculty Senator (1998-2004)
Public Service Committee (1998-2001)
Curriculum Committee (2000-2001) National Accreditation Council for Pharmacy Education onsite evaluation team member (2006 – present) American Association of Colleges Pharmacy Practice Communications Task Force (2006 – present) American Association of Colleges of Pharmacy CAPE Outcomes Task Force for Pharmacy Practice Section (2005 – 2007, chair)
|
||||||||||||||||||||||||||||||||||||||||||||||